Clinical Trial

Enhanced Recovery Protocol for Anorectal Surgery

Study Description

Prospective Randomized Controlled Trial of an Enhanced Recovery Protocol for Anorectal Surgery

The purpose of the study is to evaluate whether being randomized to an aggressive postoperative non-narcotic pain regimen that treats pain from multiple different pathways may decrease postoperative pain levels, decrease constipation, and decrease the dependency on opioid medications after anorectal surgery versus the standard of care for managing pain. This use of a more aggressive pain regimen is considered an enhanced recovery after surgery (ERAS) protocol because it is theorized to improve or "enhance" postoperative recovery by both decreasing the use of narcotics and their detrimental effects as well as increasing the benefit of using additional non-narcotic pain medication.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Combination Product - ERAS

Gabapentin Acetaminophen Ketoroloac IV (intraop) and PO Dexamethasone (included with benzocaine in local anesthesia) Oxycodone PO Polyethylene glycol

Combination Product - Standard of care

Oxcodone PO Ketorolac IV only (intraop)

Additional Information

Official Study Title

Prospective Randomized Controlled Trial of an Enhanced Recovery Protocol for Anorectal Surgery

Clinical Trial ID

NCT03738904

ParticipAid ID

dJ6Yod